Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle exocytosis (GO:0016079) | 4.46217849 |
2 | vocalization behavior (GO:0071625) | 4.40656276 |
3 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.36527552 |
4 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.33871657 |
5 | neuron cell-cell adhesion (GO:0007158) | 4.31712546 |
6 | protein localization to synapse (GO:0035418) | 4.31665308 |
7 | glutamate receptor signaling pathway (GO:0007215) | 4.27096987 |
8 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.25373570 |
9 | COPI coating of Golgi vesicle (GO:0048205) | 4.10377658 |
10 | Golgi transport vesicle coating (GO:0048200) | 4.10377658 |
11 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.04571174 |
12 | protein maturation by protein folding (GO:0022417) | 3.99691496 |
13 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.99308292 |
14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.95010259 |
15 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.93757735 |
16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.92756199 |
17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.89173285 |
18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.87436620 |
19 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.83146079 |
20 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.76872332 |
21 | regulation of synaptic vesicle transport (GO:1902803) | 3.74823968 |
22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.73909063 |
23 | exploration behavior (GO:0035640) | 3.71848065 |
24 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.71345150 |
25 | neuron recognition (GO:0008038) | 3.70402795 |
26 | synaptic transmission, glutamatergic (GO:0035249) | 3.67259114 |
27 | regulation of neuron projection regeneration (GO:0070570) | 3.67018223 |
28 | regulation of axon regeneration (GO:0048679) | 3.67018223 |
29 | neuron-neuron synaptic transmission (GO:0007270) | 3.64805500 |
30 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.63535353 |
31 | neuronal action potential propagation (GO:0019227) | 3.54284771 |
32 | detection of calcium ion (GO:0005513) | 3.48735371 |
33 | nucleobase catabolic process (GO:0046113) | 3.47448246 |
34 | response to histamine (GO:0034776) | 3.45852475 |
35 | postsynaptic membrane organization (GO:0001941) | 3.43411288 |
36 | axonemal dynein complex assembly (GO:0070286) | 3.38560765 |
37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.38193669 |
38 | fear response (GO:0042596) | 3.30462879 |
39 | regulation of vesicle fusion (GO:0031338) | 3.29458323 |
40 | long-term synaptic potentiation (GO:0060291) | 3.28977695 |
41 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.28973439 |
42 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.27377529 |
43 | behavioral defense response (GO:0002209) | 3.26953643 |
44 | behavioral fear response (GO:0001662) | 3.26953643 |
45 | regulation of postsynaptic membrane potential (GO:0060078) | 3.25680280 |
46 | intestinal epithelial cell development (GO:0060576) | 3.24775672 |
47 | presynaptic membrane assembly (GO:0097105) | 3.23050947 |
48 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.21731314 |
49 | synaptic vesicle maturation (GO:0016188) | 3.21297590 |
50 | locomotory exploration behavior (GO:0035641) | 3.20603916 |
51 | positive regulation of synapse maturation (GO:0090129) | 3.20602100 |
52 | glutamate secretion (GO:0014047) | 3.19322656 |
53 | innervation (GO:0060384) | 3.17689297 |
54 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.12583954 |
55 | negative regulation of cell killing (GO:0031342) | 3.12583954 |
56 | regulation of synapse structural plasticity (GO:0051823) | 3.10773165 |
57 | synaptic vesicle endocytosis (GO:0048488) | 3.10510241 |
58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.10251243 |
59 | axonal fasciculation (GO:0007413) | 3.09127702 |
60 | long-term memory (GO:0007616) | 3.08129178 |
61 | positive regulation of response to oxidative stress (GO:1902884) | 3.08032945 |
62 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.08032945 |
63 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.07229353 |
64 | positive regulation of neurotransmitter transport (GO:0051590) | 3.05923148 |
65 | regulation of dopamine metabolic process (GO:0042053) | 3.04313109 |
66 | regulation of catecholamine metabolic process (GO:0042069) | 3.04313109 |
67 | dendritic spine organization (GO:0097061) | 3.04187527 |
68 | positive regulation of membrane potential (GO:0045838) | 3.01595328 |
69 | cochlea development (GO:0090102) | 3.00603608 |
70 | apical protein localization (GO:0045176) | 3.00269828 |
71 | regulation of synaptic plasticity (GO:0048167) | 3.00000316 |
72 | regulation of actin nucleation (GO:0051125) | 2.98959481 |
73 | glycosphingolipid biosynthetic process (GO:0006688) | 2.97909911 |
74 | surfactant homeostasis (GO:0043129) | 2.97332364 |
75 | positive regulation of dendritic spine development (GO:0060999) | 2.97177250 |
76 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96313492 |
77 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.95532818 |
78 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.94166885 |
79 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92980172 |
80 | regulation of glutamate secretion (GO:0014048) | 2.91817108 |
81 | dendritic spine morphogenesis (GO:0060997) | 2.91087520 |
82 | neurotransmitter secretion (GO:0007269) | 2.89284049 |
83 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.88524177 |
84 | protein localization to cilium (GO:0061512) | 2.87932394 |
85 | serotonin metabolic process (GO:0042428) | 2.87615277 |
86 | catecholamine transport (GO:0051937) | 2.86653591 |
87 | negative regulation of microtubule polymerization (GO:0031115) | 2.84402352 |
88 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.84329375 |
89 | epithelial cell maturation (GO:0002070) | 2.83916600 |
90 | cellular potassium ion homeostasis (GO:0030007) | 2.82214741 |
91 | chemosensory behavior (GO:0007635) | 2.82006295 |
92 | response to amphetamine (GO:0001975) | 2.80950600 |
93 | presynaptic membrane organization (GO:0097090) | 2.79118865 |
94 | learning (GO:0007612) | 2.77175917 |
95 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.76742020 |
96 | synaptic transmission, dopaminergic (GO:0001963) | 2.76368066 |
97 | transmission of nerve impulse (GO:0019226) | 2.75766400 |
98 | establishment of synaptic vesicle localization (GO:0097480) | 2.74456347 |
99 | synaptic vesicle transport (GO:0048489) | 2.74456347 |
100 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.71105099 |
101 | long term synaptic depression (GO:0060292) | 2.71104075 |
102 | vesicle transport along microtubule (GO:0047496) | 2.70488994 |
103 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.69237665 |
104 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.68215814 |
105 | establishment of mitochondrion localization (GO:0051654) | 2.68154594 |
106 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.67159787 |
107 | sodium ion export (GO:0071436) | 2.66537808 |
108 | membrane depolarization (GO:0051899) | 2.66381074 |
109 | chemical homeostasis within a tissue (GO:0048875) | 2.65793144 |
110 | startle response (GO:0001964) | 2.65557902 |
111 | regulation of neurotransmitter secretion (GO:0046928) | 2.65247795 |
112 | layer formation in cerebral cortex (GO:0021819) | 2.65151415 |
113 | synapse assembly (GO:0007416) | 2.64945185 |
114 | activation of protein kinase A activity (GO:0034199) | 2.64772180 |
115 | righting reflex (GO:0060013) | 2.62680802 |
116 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.61994691 |
117 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.61953797 |
118 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.61813266 |
119 | endoplasmic reticulum organization (GO:0007029) | 2.58341921 |
120 | primary alcohol catabolic process (GO:0034310) | 2.58141573 |
121 | NADH metabolic process (GO:0006734) | 2.57687158 |
122 | protein retention in ER lumen (GO:0006621) | 2.57545786 |
123 | cilium movement (GO:0003341) | 2.56348759 |
124 | L-serine transport (GO:0015825) | 2.52959171 |
125 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.52303192 |
126 | norepinephrine metabolic process (GO:0042415) | 2.52277497 |
127 | vitamin transmembrane transport (GO:0035461) | 2.48270142 |
128 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.47742751 |
129 | regulation of autophagic vacuole assembly (GO:2000785) | 2.45570979 |
130 | neurotransmitter catabolic process (GO:0042135) | 2.45199741 |
131 | vesicle coating (GO:0006901) | 2.43435799 |
132 | peptidyl-cysteine modification (GO:0018198) | 2.42722816 |
133 | organelle transport along microtubule (GO:0072384) | 2.41959613 |
134 | asymmetric protein localization (GO:0008105) | 2.40972431 |
135 | neurofilament cytoskeleton organization (GO:0060052) | 2.39247318 |
136 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.38495681 |
137 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.38495681 |
138 | epithelial cilium movement (GO:0003351) | 2.37529853 |
139 | COPII vesicle coating (GO:0048208) | 2.37275467 |
140 | cell migration in hindbrain (GO:0021535) | 2.34185117 |
141 | ear development (GO:0043583) | 2.32743398 |
142 | cell communication involved in cardiac conduction (GO:0086065) | 2.31988461 |
143 | membrane budding (GO:0006900) | 2.30988798 |
144 | positive regulation of protein targeting to membrane (GO:0090314) | 2.28529138 |
145 | protein insertion into membrane (GO:0051205) | 2.26156646 |
146 | sodium ion homeostasis (GO:0055078) | 2.25972335 |
147 | neurotransmitter biosynthetic process (GO:0042136) | 2.25871092 |
148 | positive regulation of mitochondrial fission (GO:0090141) | 2.25351219 |
149 | transferrin transport (GO:0033572) | 2.25316116 |
150 | regulation of neurotransmitter levels (GO:0001505) | 2.25205312 |
151 | cellular sodium ion homeostasis (GO:0006883) | 2.24192776 |
152 | prostate gland growth (GO:0060736) | 2.24183616 |
153 | regulation of protein targeting to membrane (GO:0090313) | 2.23491149 |
154 | mating behavior (GO:0007617) | 2.22491614 |
155 | growth hormone secretion (GO:0030252) | 2.22405334 |
156 | ferric iron transport (GO:0015682) | 2.20951117 |
157 | trivalent inorganic cation transport (GO:0072512) | 2.20951117 |
158 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.20677695 |
159 | peroxisome fission (GO:0016559) | 2.20217049 |
160 | dendrite morphogenesis (GO:0048813) | 2.19995473 |
161 | establishment of melanosome localization (GO:0032401) | 2.16631699 |
162 | dopamine receptor signaling pathway (GO:0007212) | 2.15673384 |
163 | cell communication by electrical coupling (GO:0010644) | 2.15060974 |
164 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.15039360 |
165 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.15039360 |
166 | intraciliary transport (GO:0042073) | 2.14335502 |
167 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.13636961 |
168 | cerebellar Purkinje cell layer development (GO:0021680) | 2.13283182 |
169 | regulation of vacuole organization (GO:0044088) | 2.13218707 |
170 | diterpenoid biosynthetic process (GO:0016102) | 2.12680077 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.03461553 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.10046491 |
3 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.63033433 |
4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.07919405 |
5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06528591 |
6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.96931566 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.77571624 |
8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.72573221 |
9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.58233508 |
10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.54013448 |
11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.50342209 |
12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.47820356 |
13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.40778444 |
14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40496279 |
15 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.38970923 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.35592604 |
17 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.35236029 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.33341013 |
19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31796630 |
20 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.31130147 |
21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.29229536 |
22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.27091679 |
23 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.25903752 |
24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.24623924 |
25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.24623924 |
26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.21285876 |
27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.18052666 |
28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.16411256 |
29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11657126 |
30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.04972376 |
31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.04258800 |
32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.99270004 |
33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.97604278 |
34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96178081 |
35 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.94540309 |
36 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.91281883 |
37 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.91035123 |
38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90891530 |
39 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.86294737 |
40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.84937401 |
41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.83385877 |
42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.82845309 |
43 | VDR_22108803_ChIP-Seq_LS180_Human | 1.78414529 |
44 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.74571011 |
45 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74478558 |
46 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.73224162 |
47 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.70863454 |
48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.68878476 |
49 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66253399 |
50 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.62253358 |
51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58843840 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51803554 |
53 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50431096 |
54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47797758 |
55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46057322 |
56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.45856002 |
57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.44584785 |
58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.42797387 |
59 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.42582535 |
60 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41021065 |
61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40930098 |
62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32767514 |
63 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28982645 |
64 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.27086632 |
65 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.26500726 |
66 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25957740 |
67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25281543 |
68 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.24600083 |
69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22598191 |
70 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20356373 |
71 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17470442 |
72 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.16552625 |
73 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14911653 |
74 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.14415889 |
75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13786766 |
76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13042122 |
77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09567803 |
78 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.09449257 |
79 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09204509 |
80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09116235 |
81 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.07965559 |
82 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.07408926 |
83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.07384531 |
84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07364407 |
85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.06839568 |
86 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05525591 |
87 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05431966 |
88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05229479 |
89 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.04795469 |
90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04158382 |
91 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04128230 |
92 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03687312 |
93 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.02620553 |
94 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.01754112 |
95 | JUN_21703547_ChIP-Seq_K562_Human | 1.01278389 |
96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01076123 |
97 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00791806 |
98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.00211375 |
99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00006283 |
100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97960185 |
101 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.97088473 |
102 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96369441 |
103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96338682 |
104 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95910460 |
105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95831817 |
106 | EWS_26573619_Chip-Seq_HEK293_Human | 0.95732242 |
107 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95699492 |
108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95543439 |
109 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95128408 |
110 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94758903 |
111 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94276513 |
112 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93828395 |
113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.92185612 |
114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90158536 |
115 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.89896438 |
116 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.88567666 |
117 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88292714 |
118 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88142314 |
119 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.88061517 |
120 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88002240 |
121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.87810779 |
122 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86959064 |
123 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.86249571 |
124 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85946924 |
125 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85746102 |
126 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85718556 |
127 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.85248019 |
128 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85248019 |
129 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84809045 |
130 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84622355 |
131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84432866 |
132 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83717557 |
133 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.83077538 |
134 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.83077538 |
135 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.82656870 |
136 | AR_19668381_ChIP-Seq_PC3_Human | 0.82071479 |
137 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.81832875 |
138 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.81691060 |
139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.81398570 |
140 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80630553 |
141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.80242817 |
142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79999644 |
143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78716363 |
144 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.78689233 |
145 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.78558410 |
146 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.75784455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003880_abnormal_central_pattern | 5.68782394 |
2 | MP0004859_abnormal_synaptic_plasticity | 4.92006718 |
3 | MP0003635_abnormal_synaptic_transmissio | 3.59152933 |
4 | MP0004270_analgesia | 3.08423101 |
5 | MP0010234_abnormal_vibrissa_follicle | 3.07769971 |
6 | MP0004782_abnormal_surfactant_physiolog | 3.01819500 |
7 | MP0002063_abnormal_learning/memory/cond | 2.99853304 |
8 | MP0009745_abnormal_behavioral_response | 2.93184889 |
9 | MP0001968_abnormal_touch/_nociception | 2.72791150 |
10 | MP0001188_hyperpigmentation | 2.51698183 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.50989060 |
12 | MP0006276_abnormal_autonomic_nervous | 2.47082750 |
13 | MP0002736_abnormal_nociception_after | 2.40326374 |
14 | MP0002909_abnormal_adrenal_gland | 2.37166115 |
15 | MP0001501_abnormal_sleep_pattern | 2.36421929 |
16 | MP0002064_seizures | 2.35480528 |
17 | MP0002837_dystrophic_cardiac_calcinosis | 2.31094915 |
18 | MP0002272_abnormal_nervous_system | 2.24010492 |
19 | MP0004264_abnormal_extraembryonic_tissu | 2.20347107 |
20 | MP0010386_abnormal_urinary_bladder | 2.09596242 |
21 | MP0002735_abnormal_chemical_nociception | 2.09544191 |
22 | MP0005423_abnormal_somatic_nervous | 2.01714463 |
23 | MP0001529_abnormal_vocalization | 1.99037340 |
24 | MP0002734_abnormal_mechanical_nocicepti | 1.98698610 |
25 | MP0005645_abnormal_hypothalamus_physiol | 1.92707378 |
26 | MP0001440_abnormal_grooming_behavior | 1.90225258 |
27 | MP0009780_abnormal_chondrocyte_physiolo | 1.80290683 |
28 | MP0002184_abnormal_innervation | 1.78205147 |
29 | MP0002067_abnormal_sensory_capabilities | 1.75686780 |
30 | MP0002733_abnormal_thermal_nociception | 1.75080537 |
31 | MP0001486_abnormal_startle_reflex | 1.73346899 |
32 | MP0001984_abnormal_olfaction | 1.72554793 |
33 | MP0001905_abnormal_dopamine_level | 1.69065313 |
34 | MP0001970_abnormal_pain_threshold | 1.68301915 |
35 | MP0009379_abnormal_foot_pigmentation | 1.65363493 |
36 | MP0003879_abnormal_hair_cell | 1.62634108 |
37 | MP0002557_abnormal_social/conspecific_i | 1.62379099 |
38 | MP0002822_catalepsy | 1.57906570 |
39 | MP0006292_abnormal_olfactory_placode | 1.57795824 |
40 | MP0003787_abnormal_imprinting | 1.53198332 |
41 | MP0005409_darkened_coat_color | 1.53037894 |
42 | MP0005083_abnormal_biliary_tract | 1.52605483 |
43 | MP0005646_abnormal_pituitary_gland | 1.52073646 |
44 | MP0001502_abnormal_circadian_rhythm | 1.50354698 |
45 | MP0005386_behavior/neurological_phenoty | 1.50294417 |
46 | MP0004924_abnormal_behavior | 1.50294417 |
47 | MP0009046_muscle_twitch | 1.50066071 |
48 | MP0002796_impaired_skin_barrier | 1.50056887 |
49 | MP0000566_synostosis | 1.49415620 |
50 | MP0000778_abnormal_nervous_system | 1.46668213 |
51 | MP0002653_abnormal_ependyma_morphology | 1.45890079 |
52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.44207523 |
53 | MP0005379_endocrine/exocrine_gland_phen | 1.43447375 |
54 | MP0001346_abnormal_lacrimal_gland | 1.42794239 |
55 | MP0003122_maternal_imprinting | 1.42713290 |
56 | MP0000013_abnormal_adipose_tissue | 1.38459877 |
57 | MP0010678_abnormal_skin_adnexa | 1.37163806 |
58 | MP0005248_abnormal_Harderian_gland | 1.36986780 |
59 | MP0004811_abnormal_neuron_physiology | 1.36824654 |
60 | MP0002693_abnormal_pancreas_physiology | 1.34694545 |
61 | MP0008569_lethality_at_weaning | 1.28771735 |
62 | MP0003329_amyloid_beta_deposits | 1.28492257 |
63 | MP0003183_abnormal_peptide_metabolism | 1.21778468 |
64 | MP0000955_abnormal_spinal_cord | 1.21712853 |
65 | MP0002876_abnormal_thyroid_physiology | 1.21345346 |
66 | MP0002098_abnormal_vibrissa_morphology | 1.20585428 |
67 | MP0000427_abnormal_hair_cycle | 1.20435346 |
68 | MP0006072_abnormal_retinal_apoptosis | 1.20099160 |
69 | MP0001666_abnormal_nutrient_absorption | 1.19754034 |
70 | MP0000537_abnormal_urethra_morphology | 1.19624010 |
71 | MP0001727_abnormal_embryo_implantation | 1.19429238 |
72 | MP0000631_abnormal_neuroendocrine_gland | 1.19198087 |
73 | MP0000462_abnormal_digestive_system | 1.18894906 |
74 | MP0003123_paternal_imprinting | 1.14698596 |
75 | MP0002638_abnormal_pupillary_reflex | 1.14553648 |
76 | MP0001664_abnormal_digestion | 1.13632798 |
77 | MP0002160_abnormal_reproductive_system | 1.10811896 |
78 | MP0002234_abnormal_pharynx_morphology | 1.09705162 |
79 | MP0001177_atelectasis | 1.09089223 |
80 | MP0004145_abnormal_muscle_electrophysio | 1.08523232 |
81 | MP0008995_early_reproductive_senescence | 1.08325795 |
82 | MP0002882_abnormal_neuron_morphology | 1.07138309 |
83 | MP0001944_abnormal_pancreas_morphology | 1.07038594 |
84 | MP0003121_genomic_imprinting | 1.06942088 |
85 | MP0000678_abnormal_parathyroid_gland | 1.06531515 |
86 | MP0002066_abnormal_motor_capabilities/c | 1.06202023 |
87 | MP0005535_abnormal_body_temperature | 1.01907314 |
88 | MP0004215_abnormal_myocardial_fiber | 1.01768185 |
89 | MP0008789_abnormal_olfactory_epithelium | 1.00437355 |
90 | MP0004510_myositis | 0.98739242 |
91 | MP0002163_abnormal_gland_morphology | 0.96326527 |
92 | MP0004484_altered_response_of | 0.94831870 |
93 | MP0000015_abnormal_ear_pigmentation | 0.93683364 |
94 | MP0005174_abnormal_tail_pigmentation | 0.92405787 |
95 | MP0005085_abnormal_gallbladder_physiolo | 0.91515598 |
96 | MP0003633_abnormal_nervous_system | 0.90900870 |
97 | MP0005310_abnormal_salivary_gland | 0.90615818 |
98 | MP0000681_abnormal_thyroid_gland | 0.87574987 |
99 | MP0001765_abnormal_ion_homeostasis | 0.87365684 |
100 | MP0005501_abnormal_skin_physiology | 0.87051418 |
101 | MP0005394_taste/olfaction_phenotype | 0.86739763 |
102 | MP0005499_abnormal_olfactory_system | 0.86739763 |
103 | MP0001986_abnormal_taste_sensitivity | 0.85110169 |
104 | MP0004085_abnormal_heartbeat | 0.84395889 |
105 | MP0001881_abnormal_mammary_gland | 0.83340977 |
106 | MP0002069_abnormal_eating/drinking_beha | 0.83333224 |
107 | MP0000647_abnormal_sebaceous_gland | 0.82634422 |
108 | MP0002152_abnormal_brain_morphology | 0.81339475 |
109 | MP0005551_abnormal_eye_electrophysiolog | 0.81139504 |
110 | MP0000383_abnormal_hair_follicle | 0.79383942 |
111 | MP0005636_abnormal_mineral_homeostasis | 0.78393357 |
112 | MP0001919_abnormal_reproductive_system | 0.78034393 |
113 | MP0004858_abnormal_nervous_system | 0.75314746 |
114 | MP0004133_heterotaxia | 0.74508076 |
115 | MP0003283_abnormal_digestive_organ | 0.73810412 |
116 | MP0001963_abnormal_hearing_physiology | 0.73225092 |
117 | MP0004043_abnormal_pH_regulation | 0.72482399 |
118 | MP0002229_neurodegeneration | 0.71715746 |
119 | MP0008872_abnormal_physiological_respon | 0.71441533 |
120 | MP0004142_abnormal_muscle_tone | 0.71391254 |
121 | MP0003890_abnormal_embryonic-extraembry | 0.71365005 |
122 | MP0005187_abnormal_penis_morphology | 0.70653514 |
123 | MP0010329_abnormal_lipoprotein_level | 0.69638806 |
124 | MP0003942_abnormal_urinary_system | 0.67645420 |
125 | MP0002751_abnormal_autonomic_nervous | 0.67394751 |
126 | MP0004019_abnormal_vitamin_homeostasis | 0.67366763 |
127 | MP0000377_abnormal_hair_follicle | 0.65783455 |
128 | MP0003315_abnormal_perineum_morphology | 0.65424469 |
129 | MP0005084_abnormal_gallbladder_morpholo | 0.63709667 |
130 | MP0003866_abnormal_defecation | 0.63216494 |
131 | MP0008874_decreased_physiological_sensi | 0.63121969 |
132 | MP0003631_nervous_system_phenotype | 0.62794747 |
133 | MP0002877_abnormal_melanocyte_morpholog | 0.60329259 |
134 | MP0008961_abnormal_basal_metabolism | 0.59896636 |
135 | MP0004147_increased_porphyrin_level | 0.59401860 |
136 | MP0002752_abnormal_somatic_nervous | 0.58825584 |
137 | MP0005671_abnormal_response_to | 0.57680176 |
138 | MP0001873_stomach_inflammation | 0.53262539 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 6.24502810 |
2 | Visual hallucinations (HP:0002367) | 5.51867762 |
3 | Atonic seizures (HP:0010819) | 4.53964042 |
4 | Epileptic encephalopathy (HP:0200134) | 4.21417146 |
5 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.20167978 |
6 | Focal seizures (HP:0007359) | 4.13825545 |
7 | Febrile seizures (HP:0002373) | 4.01123499 |
8 | Absence seizures (HP:0002121) | 3.97958296 |
9 | Hyperventilation (HP:0002883) | 3.81350056 |
10 | Dialeptic seizures (HP:0011146) | 3.55463187 |
11 | Myokymia (HP:0002411) | 3.42565896 |
12 | Amblyopia (HP:0000646) | 3.33824918 |
13 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.25302625 |
14 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.23364451 |
15 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.23364451 |
16 | Rhinitis (HP:0012384) | 3.23137617 |
17 | Chronic bronchitis (HP:0004469) | 3.15568745 |
18 | Progressive inability to walk (HP:0002505) | 3.09445410 |
19 | Type II lissencephaly (HP:0007260) | 3.06702916 |
20 | Truncal ataxia (HP:0002078) | 3.02030016 |
21 | Anxiety (HP:0000739) | 3.01438248 |
22 | Broad-based gait (HP:0002136) | 2.97170556 |
23 | Retinal dysplasia (HP:0007973) | 2.96427139 |
24 | Ankle clonus (HP:0011448) | 2.94891610 |
25 | Protruding tongue (HP:0010808) | 2.94338238 |
26 | Decreased circulating renin level (HP:0003351) | 2.87412083 |
27 | Drooling (HP:0002307) | 2.86862272 |
28 | Excessive salivation (HP:0003781) | 2.86862272 |
29 | Supranuclear gaze palsy (HP:0000605) | 2.85448611 |
30 | Abnormality of the corticospinal tract (HP:0002492) | 2.84246835 |
31 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.81020806 |
32 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.81020806 |
33 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.75372663 |
34 | Absent/shortened dynein arms (HP:0200106) | 2.75372663 |
35 | Epileptiform EEG discharges (HP:0011182) | 2.74527198 |
36 | Inability to walk (HP:0002540) | 2.74406630 |
37 | Hypothermia (HP:0002045) | 2.71402743 |
38 | Generalized tonic-clonic seizures (HP:0002069) | 2.70828723 |
39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.69192567 |
40 | Cerebral inclusion bodies (HP:0100314) | 2.67989203 |
41 | Termporal pattern (HP:0011008) | 2.65547509 |
42 | Insidious onset (HP:0003587) | 2.65547509 |
43 | Concave nail (HP:0001598) | 2.63681173 |
44 | Urinary urgency (HP:0000012) | 2.63330132 |
45 | Depression (HP:0000716) | 2.60703408 |
46 | Poor eye contact (HP:0000817) | 2.59044725 |
47 | Delusions (HP:0000746) | 2.57477374 |
48 | Acute necrotizing encephalopathy (HP:0006965) | 2.56852336 |
49 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.53244274 |
50 | Abnormality of binocular vision (HP:0011514) | 2.51842566 |
51 | Diplopia (HP:0000651) | 2.51842566 |
52 | Hydroureter (HP:0000072) | 2.50609310 |
53 | Papilledema (HP:0001085) | 2.48519091 |
54 | EEG with generalized epileptiform discharges (HP:0011198) | 2.48025732 |
55 | Dysautonomia (HP:0002459) | 2.42887254 |
56 | Progressive cerebellar ataxia (HP:0002073) | 2.42171291 |
57 | Akinesia (HP:0002304) | 2.41617050 |
58 | Agitation (HP:0000713) | 2.40685418 |
59 | Curly hair (HP:0002212) | 2.38425259 |
60 | Papillary thyroid carcinoma (HP:0002895) | 2.36374040 |
61 | Impaired smooth pursuit (HP:0007772) | 2.35072583 |
62 | Mutism (HP:0002300) | 2.34313360 |
63 | Gait imbalance (HP:0002141) | 2.34021220 |
64 | Gout (HP:0001997) | 2.32378136 |
65 | Mitochondrial inheritance (HP:0001427) | 2.28454675 |
66 | Stereotypic behavior (HP:0000733) | 2.28014651 |
67 | Progressive macrocephaly (HP:0004481) | 2.27844790 |
68 | Hemiparesis (HP:0001269) | 2.27095668 |
69 | Psychosis (HP:0000709) | 2.26273276 |
70 | Interstitial pulmonary disease (HP:0006530) | 2.21206606 |
71 | Tubulointerstitial nephritis (HP:0001970) | 2.20575841 |
72 | Chronic sinusitis (HP:0011109) | 2.19289508 |
73 | Medial flaring of the eyebrow (HP:0010747) | 2.17595355 |
74 | Hypsarrhythmia (HP:0002521) | 2.15587526 |
75 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.14724586 |
76 | Infertility (HP:0000789) | 2.12372407 |
77 | Oligomenorrhea (HP:0000876) | 2.12050901 |
78 | Action tremor (HP:0002345) | 2.10721525 |
79 | Spastic gait (HP:0002064) | 2.09773763 |
80 | Hand muscle atrophy (HP:0009130) | 2.09660678 |
81 | Amyotrophic lateral sclerosis (HP:0007354) | 2.08995511 |
82 | Growth hormone excess (HP:0000845) | 2.07495257 |
83 | Congenital primary aphakia (HP:0007707) | 2.06345595 |
84 | Abnormal social behavior (HP:0012433) | 2.03810202 |
85 | Impaired social interactions (HP:0000735) | 2.03810202 |
86 | Hypoglycemic coma (HP:0001325) | 2.01756393 |
87 | Vaginal atresia (HP:0000148) | 1.98907125 |
88 | Diminished movement (HP:0002374) | 1.98738014 |
89 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.97921411 |
90 | Heterochromia iridis (HP:0001100) | 1.97758324 |
91 | Lissencephaly (HP:0001339) | 1.96492619 |
92 | Pheochromocytoma (HP:0002666) | 1.96148803 |
93 | Bradykinesia (HP:0002067) | 1.95872593 |
94 | Genital tract atresia (HP:0001827) | 1.95340747 |
95 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94167165 |
96 | Abnormal eating behavior (HP:0100738) | 1.93002011 |
97 | Unsteady gait (HP:0002317) | 1.92525506 |
98 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.91456243 |
99 | Muscular hypotonia of the trunk (HP:0008936) | 1.91050614 |
100 | Abnormality of salivation (HP:0100755) | 1.90789717 |
101 | Neuroendocrine neoplasm (HP:0100634) | 1.90274587 |
102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.89235810 |
103 | Absent speech (HP:0001344) | 1.88219110 |
104 | Proximal tubulopathy (HP:0000114) | 1.87947705 |
105 | Diminished motivation (HP:0000745) | 1.87281484 |
106 | Esotropia (HP:0000565) | 1.87281354 |
107 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.86401267 |
108 | Hypoplasia of the brainstem (HP:0002365) | 1.86401267 |
109 | Gaze-evoked nystagmus (HP:0000640) | 1.85369486 |
110 | Limb dystonia (HP:0002451) | 1.85229596 |
111 | Widely spaced teeth (HP:0000687) | 1.82904860 |
112 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.82716799 |
113 | Cortical dysplasia (HP:0002539) | 1.82410550 |
114 | Neurofibrillary tangles (HP:0002185) | 1.82155138 |
115 | Apathy (HP:0000741) | 1.81553653 |
116 | Macroglossia (HP:0000158) | 1.81441655 |
117 | Bronchiectasis (HP:0002110) | 1.79923305 |
118 | Poor suck (HP:0002033) | 1.79538836 |
119 | Failure to thrive in infancy (HP:0001531) | 1.78430150 |
120 | Thyroid carcinoma (HP:0002890) | 1.76305074 |
121 | Hepatocellular necrosis (HP:0001404) | 1.75828325 |
122 | Deep palmar crease (HP:0006191) | 1.75684017 |
123 | Dysmetria (HP:0001310) | 1.75241195 |
124 | Exotropia (HP:0000577) | 1.75096381 |
125 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.75092899 |
126 | Specific learning disability (HP:0001328) | 1.74976595 |
127 | Orthostatic hypotension (HP:0001278) | 1.74294923 |
128 | Abnormality of the anterior horn cell (HP:0006802) | 1.74278225 |
129 | Degeneration of anterior horn cells (HP:0002398) | 1.74278225 |
130 | Rapidly progressive (HP:0003678) | 1.73621794 |
131 | Septate vagina (HP:0001153) | 1.73298283 |
132 | Restlessness (HP:0000711) | 1.73247052 |
133 | Intention tremor (HP:0002080) | 1.72250046 |
134 | Hyperactive renin-angiotensin system (HP:0000841) | 1.71959627 |
135 | Ketoacidosis (HP:0001993) | 1.71328044 |
136 | Increased CSF lactate (HP:0002490) | 1.71291333 |
137 | Hypokinesia (HP:0002375) | 1.70983864 |
138 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.70700945 |
139 | Acute encephalopathy (HP:0006846) | 1.70318797 |
140 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.69601586 |
141 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.69512948 |
142 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.69512948 |
143 | Tongue fasciculations (HP:0001308) | 1.69109770 |
144 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.66630210 |
145 | Abnormality of renin-angiotensin system (HP:0000847) | 1.66305120 |
146 | Ulnar claw (HP:0001178) | 1.66176511 |
147 | Abnormality of permanent molar morphology (HP:0011071) | 1.65998487 |
148 | Abnormality of the dental root (HP:0006486) | 1.65998487 |
149 | Taurodontia (HP:0000679) | 1.65998487 |
150 | Renal salt wasting (HP:0000127) | 1.65547269 |
151 | Polyphagia (HP:0002591) | 1.65447230 |
152 | Right ventricular cardiomyopathy (HP:0011663) | 1.65019771 |
153 | Intestinal atresia (HP:0011100) | 1.64948657 |
154 | Hypotension (HP:0002615) | 1.63380690 |
155 | Testicular atrophy (HP:0000029) | 1.63377191 |
156 | Generalized hypopigmentation of hair (HP:0011358) | 1.63344269 |
157 | Poor coordination (HP:0002370) | 1.61566975 |
158 | Sparse lateral eyebrow (HP:0005338) | 1.61276539 |
159 | Lower limb muscle weakness (HP:0007340) | 1.61118186 |
160 | Hyperphosphatemia (HP:0002905) | 1.60940012 |
161 | Abnormal hair whorl (HP:0010721) | 1.60603352 |
162 | Abnormal ciliary motility (HP:0012262) | 1.60020353 |
163 | Tetraparesis (HP:0002273) | 1.59273718 |
164 | Autoamputation (HP:0001218) | 1.57984059 |
165 | Testicular neoplasm (HP:0010788) | 1.57910443 |
166 | Breast carcinoma (HP:0003002) | 1.55994632 |
167 | Spastic tetraplegia (HP:0002510) | 1.55338779 |
168 | Hyperaldosteronism (HP:0000859) | 1.53248977 |
169 | Hepatoblastoma (HP:0002884) | 1.48786879 |
170 | Pili torti (HP:0003777) | 1.47287750 |
171 | Sensorimotor neuropathy (HP:0007141) | 1.47230473 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NTRK3 | 4.45034688 |
2 | EPHA4 | 4.40860336 |
3 | RIPK4 | 4.24734115 |
4 | MAP3K12 | 3.70248450 |
5 | TESK1 | 3.61755621 |
6 | EPHA2 | 3.33534019 |
7 | MAP2K7 | 2.82536101 |
8 | TRIM28 | 2.59557212 |
9 | MAP3K4 | 2.58122617 |
10 | MINK1 | 2.50098109 |
11 | EIF2AK1 | 2.37231414 |
12 | CASK | 2.26073626 |
13 | MAP3K9 | 2.24624015 |
14 | DAPK1 | 2.19115185 |
15 | TNIK | 2.18286697 |
16 | MARK1 | 2.17813909 |
17 | BMPR2 | 2.15198173 |
18 | SIK2 | 1.93055826 |
19 | MST1R | 1.89786328 |
20 | LIMK1 | 1.88553723 |
21 | GRK5 | 1.82381835 |
22 | NME1 | 1.81852983 |
23 | PNCK | 1.81205513 |
24 | SIK3 | 1.77109166 |
25 | PLK2 | 1.75440251 |
26 | PKN2 | 1.74788312 |
27 | FES | 1.69854072 |
28 | KSR1 | 1.62875313 |
29 | ERBB3 | 1.62507844 |
30 | GRK6 | 1.56989665 |
31 | MAP2K4 | 1.56057835 |
32 | CDK19 | 1.55369883 |
33 | MAP3K13 | 1.54426466 |
34 | MAPK13 | 1.53125981 |
35 | ARAF | 1.43072606 |
36 | GRK7 | 1.42836897 |
37 | EPHA3 | 1.41341159 |
38 | CAMKK2 | 1.39873678 |
39 | CSNK1G3 | 1.38941656 |
40 | TSSK6 | 1.37083782 |
41 | LATS2 | 1.36524191 |
42 | INSRR | 1.36173401 |
43 | PTK2B | 1.30188150 |
44 | LMTK2 | 1.27968127 |
45 | DAPK2 | 1.27922914 |
46 | CDK5 | 1.25895872 |
47 | KSR2 | 1.23010306 |
48 | NTRK1 | 1.22775511 |
49 | MUSK | 1.18786262 |
50 | CSNK1A1L | 1.17277766 |
51 | SYK | 1.15694734 |
52 | MST4 | 1.13075210 |
53 | DYRK1A | 1.12298474 |
54 | TESK2 | 1.07428664 |
55 | CSNK1G1 | 1.06818823 |
56 | STK16 | 1.06302457 |
57 | RAF1 | 1.04661133 |
58 | CAMK2B | 1.04311291 |
59 | NTRK2 | 1.03602203 |
60 | UHMK1 | 1.02754864 |
61 | BCKDK | 1.01883587 |
62 | STK39 | 1.00222471 |
63 | CCNB1 | 0.99828533 |
64 | CAMK2A | 0.99562999 |
65 | EPHB2 | 0.99164253 |
66 | FGR | 0.96238833 |
67 | PRKCG | 0.93614706 |
68 | OXSR1 | 0.92580882 |
69 | MET | 0.91999716 |
70 | FLT3 | 0.91724541 |
71 | ADRBK2 | 0.90932977 |
72 | PRKCI | 0.89785136 |
73 | PHKG2 | 0.88947805 |
74 | PHKG1 | 0.88947805 |
75 | MAP4K2 | 0.87833966 |
76 | MAPK15 | 0.86063868 |
77 | CAMK2G | 0.82509896 |
78 | HIPK2 | 0.82338844 |
79 | TRIB3 | 0.81038469 |
80 | PINK1 | 0.80338302 |
81 | TIE1 | 0.77594137 |
82 | CAMKK1 | 0.76662490 |
83 | PIK3CA | 0.73687030 |
84 | MAP3K2 | 0.72947444 |
85 | CAMK1 | 0.72782882 |
86 | PASK | 0.72723133 |
87 | TNK2 | 0.70970271 |
88 | PRKCZ | 0.69830900 |
89 | NEK6 | 0.67862488 |
90 | STK38L | 0.60796458 |
91 | MAP3K1 | 0.59621899 |
92 | PRKCE | 0.58550692 |
93 | MAP3K6 | 0.56331488 |
94 | CAMK2D | 0.55130318 |
95 | PRKD3 | 0.53342036 |
96 | CSNK1E | 0.53324317 |
97 | RPS6KA4 | 0.53225102 |
98 | KIT | 0.52984786 |
99 | TEC | 0.52382573 |
100 | ADRBK1 | 0.51735674 |
101 | ERBB2 | 0.51080408 |
102 | YES1 | 0.50434733 |
103 | BCR | 0.48210941 |
104 | DYRK1B | 0.48002646 |
105 | LATS1 | 0.47675766 |
106 | STK24 | 0.47255234 |
107 | AKT2 | 0.46572368 |
108 | RET | 0.46482823 |
109 | PRKD2 | 0.46292761 |
110 | MYLK | 0.45874586 |
111 | CSNK1G2 | 0.45565994 |
112 | CDK14 | 0.44873157 |
113 | PTK2 | 0.43895274 |
114 | DYRK3 | 0.43878229 |
115 | MARK2 | 0.43846374 |
116 | SCYL2 | 0.42781599 |
117 | ICK | 0.42141252 |
118 | PRKAA1 | 0.42040886 |
119 | PAK6 | 0.41896627 |
120 | CDK18 | 0.41711914 |
121 | ILK | 0.40330947 |
122 | MAP2K1 | 0.40115395 |
123 | GRK1 | 0.38844450 |
124 | SRPK1 | 0.38736138 |
125 | RPS6KA2 | 0.38489643 |
126 | CSNK1A1 | 0.37795982 |
127 | MAPK12 | 0.36388782 |
128 | FER | 0.36107837 |
129 | BRAF | 0.35280373 |
130 | PRKACA | 0.33156550 |
131 | MAPKAPK5 | 0.32677319 |
132 | MAP3K7 | 0.32562027 |
133 | SGK1 | 0.32438543 |
134 | MATK | 0.32315215 |
135 | MAPKAPK3 | 0.32163109 |
136 | CDK15 | 0.32067712 |
137 | DYRK2 | 0.31534478 |
138 | CDK11A | 0.30126291 |
139 | VRK1 | 0.29170003 |
140 | BRD4 | 0.29146969 |
141 | FYN | 0.28459938 |
142 | MAP2K6 | 0.28067654 |
143 | CDK8 | 0.26747017 |
144 | PRKCQ | 0.26715986 |
145 | AKT3 | 0.25394287 |
146 | PAK3 | 0.24599258 |
147 | RPS6KB1 | 0.23825968 |
148 | CDK3 | 0.23406342 |
149 | WNK3 | 0.23094559 |
150 | LYN | 0.22596276 |
151 | FRK | 0.22312262 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.74269939 |
2 | Long-term potentiation_Homo sapiens_hsa04720 | 2.92999442 |
3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.64433846 |
4 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.60517828 |
5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.50409654 |
6 | Morphine addiction_Homo sapiens_hsa05032 | 2.27311875 |
7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.26894279 |
8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.23303505 |
9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22002692 |
10 | Taste transduction_Homo sapiens_hsa04742 | 2.21986243 |
11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.19279573 |
12 | GABAergic synapse_Homo sapiens_hsa04727 | 2.15931999 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.07441642 |
14 | Insulin secretion_Homo sapiens_hsa04911 | 2.06245810 |
15 | Salivary secretion_Homo sapiens_hsa04970 | 1.97498472 |
16 | Renin secretion_Homo sapiens_hsa04924 | 1.95062988 |
17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87308821 |
18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.85218265 |
19 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.81081584 |
20 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75108315 |
21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.73035331 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72997529 |
23 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.68455862 |
24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65880887 |
25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61203983 |
26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60215191 |
27 | Long-term depression_Homo sapiens_hsa04730 | 1.59715895 |
28 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58515780 |
29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.54598576 |
30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.54560442 |
31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.54088956 |
32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.53082993 |
33 | Cocaine addiction_Homo sapiens_hsa05030 | 1.52703546 |
34 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.52620609 |
35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.51085070 |
36 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.50023335 |
37 | Protein export_Homo sapiens_hsa03060 | 1.42138938 |
38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40804619 |
39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37615923 |
40 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.33537286 |
41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.30938844 |
42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.30006556 |
43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.27684250 |
44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23121633 |
45 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.22849671 |
46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21483883 |
47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.19581562 |
48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.18370540 |
49 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17751581 |
50 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.16058693 |
51 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15570000 |
52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.15154817 |
53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.14405111 |
54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.12121566 |
55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.10629779 |
56 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10452206 |
57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.10268560 |
58 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.07775655 |
59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.07428130 |
60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.07350320 |
61 | Gap junction_Homo sapiens_hsa04540 | 1.06318544 |
62 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05152557 |
63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03261448 |
64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.02495662 |
65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.99144934 |
66 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.98815656 |
67 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.98497081 |
68 | Phototransduction_Homo sapiens_hsa04744 | 0.98348305 |
69 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.97531157 |
70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95883189 |
71 | Mineral absorption_Homo sapiens_hsa04978 | 0.95718987 |
72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93154769 |
73 | Tight junction_Homo sapiens_hsa04530 | 0.92753983 |
74 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91414882 |
75 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.91060893 |
76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90829796 |
77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90228376 |
78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.89924574 |
79 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88222108 |
80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87310987 |
81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.86709000 |
82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86131770 |
83 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85596208 |
84 | Melanogenesis_Homo sapiens_hsa04916 | 0.83925402 |
85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.82226525 |
86 | Peroxisome_Homo sapiens_hsa04146 | 0.81331657 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81179371 |
88 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78060488 |
89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78032741 |
90 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77996647 |
91 | Glioma_Homo sapiens_hsa05214 | 0.77187051 |
92 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.77164996 |
93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75813703 |
94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75724289 |
95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75008650 |
96 | Alcoholism_Homo sapiens_hsa05034 | 0.74953515 |
97 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73047069 |
98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71400017 |
99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71346092 |
100 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.70072596 |
101 | Axon guidance_Homo sapiens_hsa04360 | 0.68766198 |
102 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.68275231 |
103 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.68194711 |
104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.68161013 |
105 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67547912 |
106 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67375156 |
107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66902716 |
108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66078190 |
109 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65465311 |
110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63587617 |
111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63090971 |
112 | Bile secretion_Homo sapiens_hsa04976 | 0.61367579 |
113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.61101183 |
114 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.61065460 |
115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.60090757 |
116 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.60086660 |
117 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58444294 |
118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56931407 |
119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56594060 |
120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.55618950 |
121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55312693 |
122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54362987 |
123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.53580007 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.51465573 |
125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.51356530 |
126 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50431604 |
127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49131762 |
128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.48438970 |
129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46962082 |
130 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.45814996 |
131 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43393851 |
132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42097308 |
133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41815514 |
134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40562823 |
135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39245996 |
136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36691802 |
137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36599689 |
138 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35440176 |
139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35238879 |
140 | Platelet activation_Homo sapiens_hsa04611 | 0.34944036 |
141 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.34081349 |
142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34036978 |
143 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33918144 |
144 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32788500 |
145 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31887904 |
146 | Shigellosis_Homo sapiens_hsa05131 | 0.31532671 |
147 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31210190 |
148 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.28500564 |
149 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.27638479 |
150 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.27254726 |
151 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.27087419 |
152 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26976248 |